By Martha Fernandez, LCSW, Licensed Clinical Social Worker and Co-Founder of CEREVITY
Founders who contact CEREVITY almost never book for the thing that ends up being treated. The stated reason is usually stress, sleep, or a specific upcoming event: a board meeting, a raise, a co-founder conversation that has been postponed twice. What assessment finds, most of the time, is an untreated depressive episode, an anxiety disorder that has been running for years, or insomnia disorder that has crossed the clinical threshold without anyone naming it. That gap between the presenting complaint and the diagnosis is the single most important thing to understand about therapy for founders, because it determines whether the first six weeks are useful or wasted.
What do founders actually present with?
Founders arriving at CEREVITY present, in rough order of frequency, with four things, and only one of them is what they came in to discuss.
Sleep is first, and it is almost always volunteered as an aside rather than a complaint. Early-morning waking at three or four with the mind already mid-argument is the specific pattern, and it is different from difficulty falling asleep. That distinction matters clinically: early waking with immediate rumination warrants a depression screen, not a sleep hygiene sheet.
Second is a narrowing of emotional range at both ends. Not sadness. Flatness. The raise closes and produces a faint procedural satisfaction that has evaporated by dinner. Founders rarely report this, because nothing hurts.
Third is alcohol, and the reporting is systematically low. The pattern is not weekend drinking, it is two or three most nights to come down from a state the body will not leave on its own.
Fourth, and the only one that reliably gets said out loud, is decision quality. A founder will say they have been making worse calls lately. That one is worth taking literally.
Why is decision quality the signal that matters most?
Decision quality degrades in founders well before any metric a board watches, because a founder’s actual output is decisions rather than hours or code, and decisions are counted nowhere.
An engineer has a test suite. A salesperson has a number. A founder deciding whether to pivot gets a verdict eighteen months later, filtered through a dozen other variables, by which point it is unfalsifiable. So the warning system every startup has is pointed downstream of the thing that is actually failing.
Four changes show up first, and founders recognise all four immediately. The option set shrinks, so a hard call that used to generate four approaches now generates two. Reversible decisions slow down while irreversible ones speed up, which inverts the one-way-door principle from Amazon’s 2015 shareholder letter and costs the most money of anything on this list. Commitment to the existing plan hardens, and the tell is the disappearance of the question about what would have to be true to be wrong. And delegation collapses precisely when load peaks, because tolerance ran out rather than time.
None of that is a personality change. Sustained cognitive load has a measurable cost, and therapy for decision fatigue targets the load rather than the founder’s judgement about the load.
Is founder burnout a diagnosis?
Founder burnout is not a diagnosis. The World Health Organization classifies burn-out in ICD-11 as an occupational phenomenon rather than a medical condition, defined as a syndrome conceptualised as resulting from chronic workplace stress that has not been successfully managed.
The practical consequence is direct: burnout by itself is not the treatment target. What gets treated is whatever has grown alongside it, and identifying which of those is present is the first job of an assessment rather than something to establish over months. CEREVITY does that in a structured diagnostic hour before any treatment plan exists, because guessing here costs a quarter.
The same logic applies to the medical differential, and skipping it is how founders end up restructuring a company to solve a physical problem. Obstructive sleep apnoea, thyroid dysfunction, iron deficiency, B12 deficiency and the after-effects of a viral illness all produce exhaustion and poor concentration that read as burnout. Anyone whose exhaustion has run for months should see a physician first.
What stops founders from starting?
Two things stop founders from starting, and stigma is neither of them.
The first is a belief that treatment will remove the edge. That fear is rational if you think the edge is made of fear. Usually it is not. Ambition, conscientiousness and high standards are stable traits, and no intervention in psychotherapy makes a person less exacting. What is treatable is the physiological bill for running those traits in a permanent threat state: the four a.m. waking, the somatic dread before an investor call, the good quarter that produces relief instead of satisfaction. Most founders are not powered by their anxiety. They are powered by something else and paying a tax on top of it.
The second is the record, and it deserves precision rather than reassurance. Private-pay care generates no insurance claim, no diagnosis code submitted to a carrier and no claims-database entry, and the clinical record sits with the treating clinician under state confidentiality law and psychotherapist-patient privilege, subject to the usual legal exceptions. Two things sit outside that. Medication is recorded at the pharmacy whoever paid for the therapy, and so is any superbill submitted to your own plan. Disclosure obligations that genuinely exist, security clearances and insurance applications among them, turn on what a specific form asks rather than on payment method, and those are questions for counsel.
What does treatment look like for someone who cannot pause?
CEREVITY treats founders on a measured, time-bound structure rather than an open-ended one, because a founder accustomed to being measured on everything will quietly disengage from a process with no way to tell whether it is working.
Validated instruments are administered at intake so the opening position is a baseline rather than a verdict, and re-run across treatment. If the numbers are not moving, the approach changes. By the third or fourth session there is an explicit formulation and a chosen approach, drawing on cognitive behavioural therapy, acceptance and commitment therapy, and psychodynamic and somatic work, matched to the formulation rather than the clinician’s preference.
Sleep gets sequenced first. If insomnia has run at least three nights a week for three months with real daytime impairment, it may meet the threshold for chronic insomnia disorder, which a clinician rather than a checklist determines, and where it does the American College of Physicians recommends cognitive behavioural therapy for insomnia as the initial treatment rather than sedatives. Where a depressive episode or anxiety disorder is identified, SSRI or SNRI medication carries first-line evidence and is often used alongside therapy, which is a prescriber conversation.
Sessions run 7am to 9pm Pacific, seven days a week, in 50-minute, 90-minute and 3-hour formats, delivered by secure video nationwide through a network of independent licensed clinicians, with a first session typically inside 48 hours. Technical founders and CTOs frequently route to therapy for CTOs and tech leaders instead, where the presenting problems overlap but the on-call and incident load changes the emphasis.
Frequently asked
Do founders need a different kind of therapy? Founders need the same evidence-based treatments as anyone else, delivered in a structure that survives a founder’s calendar and an assessment that starts from occupational reality. The modalities are not special. The sequencing, the measurement and the assumption that output will not drop are what differ.
How long does founder therapy take? Duration at CEREVITY depends on what the assessment finds rather than on a package length. A discrete anxiety presentation often moves inside a structured course of weekly work; a depressive episode with two years of untreated history takes longer, and the honest answer at intake is that the formulation by session three or four is what sets the expectation.
Will my investors find out? Investors have no route to a founder’s private-pay clinical record at CEREVITY. Confidentiality rests with the treating clinician under state law and privilege, and no claim, code or carrier entry is generated. Disclosure obligations attached to specific forms are a separate question and belong with your own counsel.
Is it worth starting during a raise? Founders who ask whether to wait until after a raise are usually asking the wrong sequencing question, because a raise is precisely when decision quality matters most and when founders are least willing to examine it. Most people do not need to step back from the company to begin.
One exception to everything above. Thoughts of death or of harming yourself are not a point on the burnout spectrum. In the United States, 988 reaches the Suicide and Crisis Lifeline at any hour.
This article is general information and is not individual medical or mental health advice. If you are concerned about your own symptoms, speak with a licensed clinician or your physician.
About the author
Martha Fernandez, LCSW is a Licensed Clinical Social Worker, licensed in California, and Co-Founder of CEREVITY, a nationwide private-pay network of independent licensed clinicians treating founders, executives, attorneys and commercial pilots. USC-trained and bilingual in English and Spanish, she works on burnout, anxiety and depression in high performers, as well as trauma, grief and high-stakes transitions.
